Skip to main content
Caplight Logo









Cellevolve Bio

Cellevolve Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://nikkigrahamtranix.com

Last Round

Seed

Nov 18, 2021

Total Funding Raised

$6M

Company Overview

Cellevolve Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in November 2021.

Cellevolve Bio is a biotechnology company that develops and commercializes cell therapies for neglected diseases, including pediatric and rare conditions, through an integrated clinical development and commercialization platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cellevolve Bio Comparables

Compare Cellevolve Bio with similar companies based on industry and business-model similarity.

Cellevolve Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainChild Bio, Inc.
79%
ElevateBio
69%
Kincell Bio
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cellevolve Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cellevolve Bio Investors

Notable investors and investment history

Cellevolve Bio investors
InvestorRounds
Hibiscus BioVenturesSeed
Catalytic Impact FoundationSeed
Jumpstart NovaSeed
Boxcar PartnersSeed

Cellevolve Bio Filings

Explore SEC and related filing metadata, where available.

Cellevolve Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cellevolve Bio's valuation, stock price, and market status.

Is Cellevolve Bio a public or private company?

Cellevolve Bio is a private company.

What is the current stock price of Cellevolve Bio?

Cellevolve Bio is a private company, so its shares have no public market price. Caplight tracks Cellevolve Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cellevolve Bio worth (valuation)?

Valuation information for Cellevolve Bio is not publicly available.

Can I buy Cellevolve Bio stock?

Cellevolve Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cellevolve Bio's last funding round?

Cellevolve Bio's most recent funding round was Seed on November 18, 2021.

Who are the main investors in Cellevolve Bio?

Key investors in Cellevolve Bio include Hibiscus BioVentures, Catalytic Impact Foundation, Jumpstart Nova, Boxcar Partners.

Will Cellevolve Bio IPO soon?

No public IPO plans have been announced for Cellevolve Bio.

How can I track Cellevolve Bio secondary market activity?

Caplight tracks bids, offers, and trades in Cellevolve Bio's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range1
Year Founded2021
Last FundingNov 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?